Risk of fracture after bariatric surgery in the United Kingdom: Population based, retrospective cohort study

BMJ (Online)

Volumn 345, Issue 7873, 2012, Pages

  Lalmohamed, Arief ^a   De Vries, Frank ^a,b,c   Bazelier, Marloes T ^a   Cooper, Alun ^d   Van Staa, Tjeerd Pieter ^a,b,e   Cooper, Cyrus ^b,f   Harvey, Nicholas C ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Bridge Medical Centre   (United Kingdom)

^e MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIOBESITY AGENT; ANXIOLYTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DIURETIC AGENT; GLUCOCORTICOID; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PROTON PUMP INHIBITOR; VITAMIN D;

ADULT; AGE; ARTICLE; BARIATRIC SURGERY; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRACTURE; FRAGILITY FRACTURE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; NONOSTEOPOROTIC FRACTURE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX; SURGICAL PATIENT; SURGICAL TECHNIQUE; UNITED KINGDOM; BONE DENSITY; CASE CONTROL STUDY; EPIDEMIOLOGY; OBESITY; OSTEOLYSIS; PHYSIOLOGY; RISK FACTOR; STATISTICS; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; BODY MASS INDEX; BONE DENSITY; BONE RESORPTION; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; FRACTURES, BONE; GREAT BRITAIN; HUMANS; MALE; OBESITY; OSTEOPOROTIC FRACTURES; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84866101389     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e5085     Document Type: Article

References (46)

1. Björntorp P. Obesity. Lancet 1997;350:423-6.
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-41.
3. Martin LF, Hunter SM, Lauve RM, O'Leary JP. Severe obesity: expensive to society, frustrating to treat, but important to confront. South Med J 1995;88:895-902.
4. Stunkard AJ. Current views on obesity. Am J Med 1996;100:230-6.
5. Kolanowski J. Surgical treatment for morbid obesity. Br Med Bull 1997;53:433-44.
6. Giusti V, Gasteyger C, Suter M, Heraief E, Gaillard RC, Burckhardt P. Gastric banding induces negative bone remodelling in the absence of secondary hyperparathyroidism: potential role of serum C telopeptides for follow-up. Int J Obes (Lond) 2005;29:1429-35.
7. Cundy T, Evans MC, Kay RG, Dowman M, Wattie D, Reid IR. Effects of vertical-banded gastroplasty on bone and mineral metabolism in obese patients. Br J Surg 1996;83:1468-72.
8. Olmos JM, Vázquez LA, Amado JA, Hernández JL, González Macías J. Mineral metabolism in obese patients following vertical banded gastroplasty. Obes Surg 2008;18:197-203.
9. Pugnale N, Giusti V, Suter M, Zysset E, Heraief E, Gaillard RC, et al. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women. Int J Obes (Lond) 2003;27:110-6.
10. Guney E, Kisakol G, Ozgen G, Yilmaz C, Yilmaz R, Kabalak T. Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention. Obes Surg 2003;13:383-8.
11. DiGiorgi M, Daud A, Inabnet WB, Schrope B, Urban-Skuro M, Restuccia N, et al. Markers of bone and calcium metabolism following gastric bypass and laparoscopic adjustable gastric banding. Obes Surg 2008;18:1144-8.
12. Reid IR. Relationships among body mass, its components, and bone. Bone 2002;31:547-55.
13. Meier CA, Bobbioni E, Gabay C, Assimacopoulos-Jeannet F, Golay A, Dayer J-M. IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab 2002;87:1184-8.
14. Bano G, Rodin DA, Pazianas M, Nussey SS. Reduced bone mineral density after surgical treatment for obesity. Int J Obes (Lond) 1999;23:361-5.
15. Adachi Y, Shiota E, Matsumata T, Iso Y, Yoh R, Kitano S. Osteoporosis after gastrectomy: bone mineral density of lumbar spine assessed by dual-energy X-ray absorptiometry. Calcif Tissue Int 2000;66:119-22.
16. Marceau P, Biron S, Lebel S, Marceau S, Hould FS, Simard S, et al. Does bone change after biliopancreatic diversion? J Gastrointest Surg 2002;6:690-8.
17. Newbury L, Dolan K, Hatzifotis M, Low N, Fielding G. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 2003;13:893-5.
18. Slater GH, Ren CJ, Siegel N, Williams T, Barr D, Wolfe B, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 2004;8:48-55.
19. Hamoui N, Kim K, Anthone G, Crookes PF. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg 2003;138:891-7.
20. Chapin BL, LeMar HJ, Knodel DH, Carter PL. Secondary hyperparathyroidism following biliopancreatic diversion. Arch Surg 1996;131:1048-52.
21. Valderas JP, Velasco S, Solari S, Liberona Y, Viviani P, Maiz A, et al. Increase of bone resorption and the parathyroid hormone in postmenopausal women in the long-term after Roux-en-Y gastric bypass. Obes Surg 2009;19:1132-8.
22. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 2004;89:1061-5.
23. Von Mach M-A, Stoeckli R, Bilz S, Kraenzlin M, Langer I, Keller U. Changes in bone mineral content after surgical treatment of morbid obesity. Metab Clin Exp 2004;53:918-21.
24. Goode LR, Brolin RE, Chowdhury HA, Shapses SA. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res 2004;12:40-7.
25. Vilarrasa N, Gómez JM, Elio I, Gómez-Vaquero C, Masdevall C, Pujol J, et al. Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss. Obes Surg 2009;19:860-6.
26. Gómez JM, Vilarrasa N, Masdevall C, Pujol J, Solano E, Soler J, et al. Regulation of bone mineral density in morbidly obese women: a cross-sectional study in two cohorts before and after bypass surgery. Obes Surg 2009;19:345-50.
27. Johnson JM, Maher JW, Samuel I, Heitshusen D, Doherty C, Downs RW. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D. J Gastrointest Surg 2005;9:1106-10.
28. Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HG. The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 2000;9:359-66.
29. Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010;69:4-14.
30. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010;60:e128-36.
31. Lewis JD, Brensinger C. Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey. Pharmacoepidemiol Drug Saf 2004;13:437-41.
32. FRAX. WHO Fracture Risk Assessment Tool. 2001. shef.ac.uk. www.shef.ac.uk/FRAX/ charts.jsp.
33. Lalmohamed A, Welsing PMJ, Lems WF, Jacobs JWG, Kanis JA, Johansson H, et al. Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures. Osteoporos Int 2012;23:861-9.
34. Pouwels S, Lalmohamed A, Leufkens B, de Boer A, Cooper C, van Staa T, et al. Risk of hip/femur fracture after stroke: a population-based case-control study. Stroke 2009;40:3281-5.
35. Pouwels S, Lalmohamed A, Souverein P, Cooper C, Veldt BJ, Leufkens HG, et al. Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study. Osteoporos Int 2011;22:903-10.
36. Pouwels S, Van Staa TP, Egberts ACG, Leufkens HGM, Cooper C, De Vries F. Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study. Osteoporos Int 2009;20:1499-506.
37. De Vries F, Pouwels S, Lammers JWJ, Leufkens HGM, Bracke M, Cooper C, et al. Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study. J Intern Med 2007;261:170-7.
38. Lalmohamed A, Vestergaard P, Klop C, Grove EL, de Boer A, Leufkens HG, et al. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study. Arch Intern Med 2012, 23 July, doi:10.1001/archinternmed.2012. 2713.
39. De Laet C, Kanis JA, Odén A, Johanson H, Johnell O, Delmas P, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int 2005;16:1330-8.
40. Nakamura K, Haglind E, Clowes J, Achenbach S, Atkinson E, Melton LJ, et al. ENDO conference abstract: fracture risk after bariatric surgery. ENDO Conference, 2009.
41. Recker R, Lappe J, Davies K, Heaney R. Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 2000;15:1965-73.
42. Vié M, Vasconcelos RS de, Neves AP, Diniz ET, Bandeira F. Bariatric surgery and bone metabolism: a systematic review. Arq Bras Endocrinol Metabol 2010;54:158-63.
43. Leff DR, Heath D. Surgery for obesity in adulthood. BMJ 2009;339:b3402.
44. Van Loan MD, Johnson HL, Barbieri TF. Effect of weight loss on bone mineral content and bone mineral density in obese women. Am J Clin Nutr 1998;67:734-8.
45. Madsen OR, Jensen JE, Sørensen OH. Validation of a dual energy X-ray absorptiometer: measurement of bone mass and soft tissue composition. Eur J Appl Physiol Occup Physiol 1997;75:554-8.
46. Sjöström L, Lindroos A, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Eng J Med 2004;351:2683-93.